Genzyme Corporate Comm is categorized under Biotechnology Products and Services in Cambridge, MA .
Genzyme Corporate Comm was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Henry Termeer, President at the company’s single location by writing to 500 Kendall St, Cambridge, Massachusetts MA 02142 or by phoning (617) 252-7570. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Genzyme Corporate Comm |
| Contact Person: | Henry Termeer, President |
| Address: | 500 Kendall St, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 252-7570 |
| Website Address: | genzyme.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biotechnology Products and Services |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
Genzyme Corporate Comm was started in 0 to provide professional Biotechnology Products and Services under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Henry Termeer, President for inquiries that concern Genzyme Corporate Comm by calling the company number (617) 252-7570, as your correspondence is most welcome. Additionally, the physical location of the single location of Genzyme Corporate Comm can be found at the coordinates 42.36393,-71.08174 as well as the street address 500 Kendall St in Cambridge, Massachusetts 02142.
For its online presence, you may visit Genzyme Corporate Comm’s website at genzyme.com and engage with its social media outlets through on Twitter and on Facebook.